• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MOTS-c:一种有前途的治疗性利用的线粒体衍生肽。

MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation.

机构信息

Environmental and Operational Medicine Research Department, Academy of Military Medical Sciences, Academy of Military Sciences, Tianjin, China.

Tianjin Key Lab of Exercise Physiology and Sports Medicine, Tianjin University of Sport, Tianjin, China.

出版信息

Front Endocrinol (Lausanne). 2023 Jan 25;14:1120533. doi: 10.3389/fendo.2023.1120533. eCollection 2023.

DOI:10.3389/fendo.2023.1120533
PMID:36761202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9905433/
Abstract

Mitochondrial ORF of the 12S rRNA Type-C (MOTS-c) is a mitochondrial-derived peptide composed of 16 amino acids encoded by the 12S rRNA region of the mitochondrial genome. The MOTS-c protein is transferred to the nucleus during metabolic stress and directs the expression of nuclear genes to promote cell balance. Different tissues co-expressed the protein with mitochondria, and plasma also contained the protein, but its level decreased with age. In addition, MOTS-c has been shown to improve glucose metabolism in skeletal muscle, which indicates its benefits for diseases such as diabetes, obesity, and aging. Nevertheless, MOTS-c has been used less frequently in disease treatment, and no effective method of applying MOTS-c in the clinic has been developed. Throughout this paper, we discussed the discovery and physiological function of mitochondrial-derived polypeptide MOTS-c, and the application of MOTS-c in the treatment of various diseases, such as aging, cardiovascular disease, insulin resistance, and inflammation. To provide additional ideas for future research and development, we tapped into the molecular mechanisms and therapeutic potentials of MOTS-c to improve diseases and combined the technology with synthetic biology in order to offer a new approach to its development and application.

摘要

MOTS-c 是一种由线粒体基因组 12S rRNA 区域编码的 16 个氨基酸组成的线粒体衍生肽。在代谢应激时,MOTS-c 蛋白被转移到细胞核内,并指导核基因的表达,从而促进细胞平衡。不同的组织与线粒体共同表达该蛋白,而血浆中也含有该蛋白,但随着年龄的增长其水平会下降。此外,MOTS-c 已被证明可改善骨骼肌中的葡萄糖代谢,这表明它对糖尿病、肥胖症和衰老等疾病有益。然而,MOTS-c 在疾病治疗中的应用较少,并且尚未开发出有效的 MOTS-c 临床应用方法。本文讨论了线粒体衍生多肽 MOTS-c 的发现和生理功能,以及 MOTS-c 在治疗衰老、心血管疾病、胰岛素抵抗和炎症等各种疾病方面的应用。为了为未来的研究和开发提供更多思路,我们探讨了 MOTS-c 的分子机制和治疗潜力,以改善疾病,并将该技术与合成生物学相结合,为其开发和应用提供新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b41/9905433/690b09403310/fendo-14-1120533-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b41/9905433/dc2146b07117/fendo-14-1120533-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b41/9905433/690b09403310/fendo-14-1120533-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b41/9905433/dc2146b07117/fendo-14-1120533-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b41/9905433/690b09403310/fendo-14-1120533-g002.jpg

相似文献

1
MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation.MOTS-c:一种有前途的治疗性利用的线粒体衍生肽。
Front Endocrinol (Lausanne). 2023 Jan 25;14:1120533. doi: 10.3389/fendo.2023.1120533. eCollection 2023.
2
MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases.MOTS-c:人类衰老及衰老相关疾病中最新的线粒体衍生肽。
Int J Mol Sci. 2022 Oct 9;23(19):11991. doi: 10.3390/ijms231911991.
3
Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging.线粒体衍生肽 MOTS-c:与应激、代谢和衰老相关的作用和机制。
J Transl Med. 2023 Jan 20;21(1):36. doi: 10.1186/s12967-023-03885-2.
4
Increased expression of the mitochondrial derived peptide, MOTS-c, in skeletal muscle of healthy aging men is associated with myofiber composition.健康老年男性骨骼肌中线粒体衍生肽 MOTS-c 的表达增加与肌纤维组成有关。
Aging (Albany NY). 2020 Mar 17;12(6):5244-5258. doi: 10.18632/aging.102944.
5
Adiponectin treatment improves insulin resistance in mice by regulating the expression of the mitochondrial-derived peptide MOTS-c and its response to exercise via APPL1-SIRT1-PGC-1α.脂联素通过调节线粒体衍生肽 MOTS-c 的表达及其对 APPL1-SIRT1-PGC-1α 的反应来改善小鼠的胰岛素抵抗。
Diabetologia. 2020 Dec;63(12):2675-2688. doi: 10.1007/s00125-020-05269-3. Epub 2020 Sep 3.
6
Exercise, Mitohormesis, and Mitochondrial ORF of the 12S rRNA Type-C (MOTS-c).运动、线粒体激素与线粒体 12S rRNA 型-C(MOTS-c)的开放阅读框。
Diabetes Metab J. 2022 May;46(3):402-413. doi: 10.4093/dmj.2022.0092. Epub 2022 May 25.
7
MOTS-c: A potential anti-pulmonary fibrosis factor derived by mitochondria.线粒体衍生的促动力蛋白2:一种潜在的抗肺纤维化因子。
Mitochondrion. 2023 Jul;71:76-82. doi: 10.1016/j.mito.2023.06.002. Epub 2023 Jun 10.
8
Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases.线粒体编码肽 MOTS-c、糖尿病与衰老相关疾病。
Diabetes Metab J. 2023 May;47(3):315-324. doi: 10.4093/dmj.2022.0333. Epub 2023 Feb 24.
9
MOTS-c Functionally Prevents Metabolic Disorders.运动诱导线粒体小分子伴侣(MOTS-c)在功能上可预防代谢紊乱。
Metabolites. 2023 Jan 13;13(1):125. doi: 10.3390/metabo13010125.
10
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.线粒体衍生肽MOTS-c可促进代谢稳态,减轻肥胖和胰岛素抵抗。
Cell Metab. 2015 Mar 3;21(3):443-54. doi: 10.1016/j.cmet.2015.02.009.

引用本文的文献

1
Characterization of the Avian Mitochondrial-Derived Peptide MOTS-c and Its Potential Role as a Metabolic Regulator.禽源线粒体衍生肽MOTS-c的特性及其作为代谢调节剂的潜在作用。
Animals (Basel). 2025 Jul 29;15(15):2230. doi: 10.3390/ani15152230.
2
Circulating mitochondrial biomarkers in acute coronary syndrome.急性冠状动脉综合征中的循环线粒体生物标志物
Front Med (Lausanne). 2025 May 15;12:1568305. doi: 10.3389/fmed.2025.1568305. eCollection 2025.
3
MOTS-c: Magical Molecule for Diabetic Cardiomyopathy?MOTS-c:糖尿病心肌病的神奇分子?

本文引用的文献

1
Mitochondrial derived peptide MOTS-c prevents the development of heart failure under pressure overload conditions in mice.线粒体衍生肽 MOTS-c 可预防小鼠在压力超负荷条件下发生心力衰竭。
J Cell Mol Med. 2022 Nov;26(21):5369-5378. doi: 10.1111/jcmm.17551. Epub 2022 Sep 25.
2
Intestinal transgene delivery with native E. coli chassis allows persistent physiological changes.利用天然大肠杆菌底盘进行肠道转基因递送可实现持续的生理变化。
Cell. 2022 Aug 18;185(17):3263-3277.e15. doi: 10.1016/j.cell.2022.06.050. Epub 2022 Aug 4.
3
Spatiotemporal control of engineered bacteria to express interferon-γ by focused ultrasound for tumor immunotherapy.
Cardiovasc Drugs Ther. 2025 Jun;39(3):473-476. doi: 10.1007/s10557-025-07689-y. Epub 2025 Apr 2.
4
MOTS-c Levels and Sarcopenia Risk in Chronic Peritoneal Dialysis Patients: A Pilot Study.慢性腹膜透析患者中MOTS-c水平与肌肉减少症风险:一项初步研究。
Medicina (Kaunas). 2025 Feb 12;61(2):322. doi: 10.3390/medicina61020322.
5
Non-canonical ORFs-derived protein products in mitochondria: A multifaceted exploration of their functions in health and disease.线粒体中源自非规范开放阅读框的蛋白质产物:对其在健康与疾病中功能的多方面探索。
Protein Sci. 2025 Mar;34(3):e70053. doi: 10.1002/pro.70053.
6
Exploring the therapeutic potential of MOTS-c in age-related macular degeneration: from cellular responses to patient-derived cybrids.探索线粒体编码的小热休克蛋白C在年龄相关性黄斑变性中的治疗潜力:从细胞反应到患者来源的胞质杂种。
Hum Cell. 2025 Feb 17;38(2):57. doi: 10.1007/s13577-025-01188-w.
7
The Relationship Between MOTS-c K14Q Polymorphism and Sarcopenia, Blood Lipids, and Mental Health in Older Korean Adults.韩国老年人群中 MOTS-c K14Q 多态性与肌肉减少症、血脂及心理健康的关系
Biomedicines. 2024 Oct 18;12(10):2384. doi: 10.3390/biomedicines12102384.
8
The Antinociceptive Role of Nrf2 in Neuropathic Pain: From Mechanisms to Clinical Perspectives.Nrf2在神经性疼痛中的抗伤害感受作用:从机制到临床展望
Pharmaceutics. 2024 Aug 15;16(8):1068. doi: 10.3390/pharmaceutics16081068.
9
The current insights of mitochondrial hormesis in the occurrence and treatment of bone and cartilage degeneration.线粒体应激在骨与软骨退变发生和治疗中的最新认识。
Biol Res. 2024 Jun 1;57(1):37. doi: 10.1186/s40659-024-00494-1.
10
Noncanonical microprotein regulation of immunity.非典型微小蛋白对免疫的调控。
Mol Ther. 2024 Sep 4;32(9):2905-2929. doi: 10.1016/j.ymthe.2024.05.021. Epub 2024 May 11.
利用聚焦超声时空控制工程菌表达干扰素-γ进行肿瘤免疫治疗。
Nat Commun. 2022 Aug 2;13(1):4468. doi: 10.1038/s41467-022-31932-x.
4
Decorated bacteria and the application in drug delivery.经修饰的细菌及其在药物传递中的应用。
Adv Drug Deliv Rev. 2022 Sep;188:114443. doi: 10.1016/j.addr.2022.114443. Epub 2022 Jul 9.
5
Exercise, Mitohormesis, and Mitochondrial ORF of the 12S rRNA Type-C (MOTS-c).运动、线粒体激素与线粒体 12S rRNA 型-C(MOTS-c)的开放阅读框。
Diabetes Metab J. 2022 May;46(3):402-413. doi: 10.4093/dmj.2022.0092. Epub 2022 May 25.
6
Bacterially mediated drug delivery and therapeutics: Strategies and advancements.细菌介导的药物递送与治疗:策略与进展
Adv Drug Deliv Rev. 2022 Aug;187:114363. doi: 10.1016/j.addr.2022.114363. Epub 2022 May 29.
7
Mitochondria-derived peptides in aging and healthspan.线粒体衍生肽与衰老和健康寿命。
J Clin Invest. 2022 May 2;132(9). doi: 10.1172/JCI158449.
8
Progress of engineered bacteria for tumor therapy.工程菌在肿瘤治疗中的研究进展。
Adv Drug Deliv Rev. 2022 Jun;185:114296. doi: 10.1016/j.addr.2022.114296. Epub 2022 Apr 16.
9
MOTS-c and Exercise Restore Cardiac Function by Activating of NRG1-ErbB Signaling in Diabetic Rats.MOTS-c 通过激活糖尿病大鼠 NRG1-ErbB 信号恢复心脏功能。
Front Endocrinol (Lausanne). 2022 Mar 17;13:812032. doi: 10.3389/fendo.2022.812032. eCollection 2022.
10
Mitochondrial-Derived Peptides in Diabetes and Its Complications.糖尿病及其并发症中的线粒体衍生肽。
Front Endocrinol (Lausanne). 2022 Feb 3;12:808120. doi: 10.3389/fendo.2021.808120. eCollection 2021.